Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accretive, Acumen, Aducanumab, allied, Alzheimer, amyloid, antagonist, antidote, antiviral, Aptevo, Aricept, Austria, Bapineuzumab, Battelle, beta, biospecific, blockade, Brain, broader, Burkholderia, buying, Camden, CEO, Chimp, Chinese, CHO, cholinesterase, CIHR, civilian, Cognex, consummated, consummation, covenant, Crenezumab, Crohn, cSNK, culminate, cytokine, deferral, dengue, discernible, EBOZ, EID, Eisai, Eli, Emergard, engineered, enterprise, Entyvio, epitope, ERP, evolved, Exelon, explicitly, figured, GMP, hamster, harmonized, HUMIRA, iminosugar, imminent, immunopathological, immunosuppressive, implicitly, Imputation, Index, inhibiting, inhibition, insoluble, ITAR, leader, Lilly, Lonza, mAb, meaningfully, Memorial, monomer, MVA, Namenda, NanoBio, Nemera, neurodegeneration, neurotoxic, NMDA, noncurrent, oligomer, oligomeric, oltertuzumab, ovary, partnership, perioperative, Pharma, PII, PIII, plaque, play, Ponezumab, proven, Razadyne, recast, Remicade, reprotoxicity, retrospective, retrospectively, seasoned, Senegal, Solanezumab, soluble, split, Stelara, subcutaneously, Subtopic, suppression, Takeda, thirteen, today, Traffic, unchanged, Unither, unlock, unrestricted, unvested, UV, UVX, Virology, Xeljanz
Removed:
BCA, budget, cancellation, collectibility, committing, conclusion, controlling, created, CVR, dating, deficit, developmental, diversifying, dosed, encourage, enforcing, EPDU, EUA, exclude, extending, extension, focusing, Frederick, headcount, improvement, initially, interference, led, MD, nonrecurring, noted, OETC, optimization, organic, outage, recovery, refractory, renovated, represent, representative, repurchase, reserved, revoked, sequestration, straight, Thravixa, trademark, twelve, unspecified, venture
Filing tables
Filing exhibits
Related press release
EBS similar filings
Filing view
External links
EXHIBIT 21
LIST OF SUBSIDIARIES
Name of Subsidiary | Jurisdiction of Incorporation or Organization |
Domestic | |
400 Professional LLC | Delaware |
Aptevo BioTherapeutics LLC | Delaware |
Aptevo Therapeutics Inc. | Delaware |
Cangene bioPharma, LLC | Maryland |
Cangene Plasma Resources, Inc. | Florida |
Emergent Commercial Operations Frederick Inc. | Maryland |
Emergent Biodefense Operations Lansing LLC | Delaware |
Emergent Europe Inc. | Delaware |
Emergent International Inc. | Delaware |
Emergent Manufacturing Operations Baltimore LLC | Delaware |
Emergent Product Development Gaithersburg Inc. | Delaware |
Emergent Product Development Seattle, LLC | Delaware |
Emergent Protective Products USA Inc. | Delaware |
Emergent Virology LLC | Delaware |
International | |
3579299 Manitoba Ltd. | Manitoba |
Cangene Corporation | Ontario |
Cangene Europe Limited | England |
CNJ Holdings Inc. | Manitoba |
Emergent BioSolutions Malaysia SDN. BHD. | Malaysia |
Emergent Countermeasures International Ltd. | England |
Emergent Global Health Foundation Limited | England |
Emergent Product Development Germany GmbH | Germany |
Emergent Product Development UK Limited | England |
Emergent Protective Products Canada ULC | Canada |
Emergent Sales and Marketing Australia Pty Limited | Australia |
Emergent Sales and Marketing Germany GmbH | Germany |
Emergent Sales and Marketing Singapore Pte. Ltd. | Singapore |
EPIC Bio Pte. Limited | Singapore |